Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus
JAMA Oncology - United States
doi 10.1001/jamaoncol.2018.5441
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2019
Authors
Publisher
American Medical Association (AMA)